COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Daniel Prieto‐Alhambra, Anthony G. Sena et al.|Lara D. Veeken|2021Cited by 53
Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network studyAnastasiya Nestsiarovich, Christophe G Lambert, Seng Chan You et al.|Translational Psychiatry|2021Cited by 51
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular OutcomesRohan Khera, Patrick B. Ryan, Arya Aminorroaya et al.|Journal of the American College of Cardiology|2024Cited by 33
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Marc A. Suchard, Lovedeep Singh Dhingra et al.|BMJ Medicine|2023Cited by 27
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Nicole G. Weiskopf, Talita Duarte‐Salles et al.|Clinical Epidemiology|2022Cited by 26